FG Merger II (FGMC)
Market Price (6/27/2026): $10.21 | Market Cap: $105.1 MilSector: Financials | Industry: Multi-Sector Holdings
FG Merger II (FGMC)
Market Price (6/27/2026): $10.21Market Cap: $105.1 MilSector: FinancialsIndustry: Multi-Sector Holdings
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Weak multi-year price returns2Y Excs Rtn is -73%, 3Y Excs Rtn is -164% Meaningful short interestShort Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 11% | Very low revenueRev LTMTotal Revenue or Sales, Last Twelve Months is 0 Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -1.1 Mil Expensive valuation multiplesP/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 60x, P/EPrice/Earnings or Price/(Net Income) is 75x Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.0% Key risksFGMC key risks include [1] failure to complete the proposed Boxabl merger, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -73%, 3Y Excs Rtn is -164% |
| Meaningful short interestShort Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 11% |
| Very low revenueRev LTMTotal Revenue or Sales, Last Twelve Months is 0 |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -1.1 Mil |
| Expensive valuation multiplesP/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 60x, P/EPrice/Earnings or Price/(Net Income) is 75x |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.0% |
| Key risksFGMC key risks include [1] failure to complete the proposed Boxabl merger, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Updated on 6/18/2026
FG Merger II (FGMC) stock has remained largely at the same level since 2/28/2026 because of the following key factors:
1. SPAC Trust Value and Redemption Price as a Floor: FG Merger II's stock largely remained at its foundational level due to its nature as a Special Purpose Acquisition Company (SPAC), where the trust value and redemption price typically act as a floor for the share price as a business combination approaches. The redemption price for FGMC was approximately $10.40 per share as of June 5, 2026, which anchored the stock's trading range.
2. High Share Redemptions Ahead of Merger: A significant number of shares, approximately 6,615,950, were tendered for redemption by the June 5, 2026 deadline, leading to the removal of about $68.8 million from the trust account. This high redemption rate, while common in de-SPAC transactions, reduced the public float to roughly 1,384,050 shares and the cash remaining in the trust to approximately $14 million, limiting potential upward price momentum before the merger.
Show more
FG Merger II (FGMC) stock has remained largely at the same level since 2/28/2026 because of the following key factors:
1. SPAC Trust Value and Redemption Price as a Floor: FG Merger II's stock largely remained at its foundational level due to its nature as a Special Purpose Acquisition Company (SPAC), where the trust value and redemption price typically act as a floor for the share price as a business combination approaches. The redemption price for FGMC was approximately $10.40 per share as of June 5, 2026, which anchored the stock's trading range.
2. High Share Redemptions Ahead of Merger: A significant number of shares, approximately 6,615,950, were tendered for redemption by the June 5, 2026 deadline, leading to the removal of about $68.8 million from the trust account. This high redemption rate, while common in de-SPAC transactions, reduced the public float to roughly 1,384,050 shares and the cash remaining in the trust to approximately $14 million, limiting potential upward price momentum before the merger.
Show more
Updated on 6/18/2026
FG Merger II (FGMC) stock has remained largely at the same level since 2/28/2026 because of the following key factors:
1. SPAC Trust Value and Redemption Price as a Floor: FG Merger II's stock largely remained at its foundational level due to its nature as a Special Purpose Acquisition Company (SPAC), where the trust value and redemption price typically act as a floor for the share price as a business combination approaches. The redemption price for FGMC was approximately $10.40 per share as of June 5, 2026, which anchored the stock's trading range.
2. High Share Redemptions Ahead of Merger: A significant number of shares, approximately 6,615,950, were tendered for redemption by the June 5, 2026 deadline, leading to the removal of about $68.8 million from the trust account. This high redemption rate, while common in de-SPAC transactions, reduced the public float to roughly 1,384,050 shares and the cash remaining in the trust to approximately $14 million, limiting potential upward price momentum before the merger.
3. Structured Capital Management via Forward Purchase Agreement: To manage capital post-redemptions, FG Merger II Corp. entered into an OTC Equity Prepaid Forward Transaction on May 28, 2026. This agreement, partly novated to an affiliate of FGMC's officers and directors, allowed for the potential purchase and holding of up to 3,000,000 shares at a reference price starting at $10.00. This mechanism was designed to provide access to additional growth capital in place of redeemed trust assets, contributing to the stock's stability around its trust value by mitigating the impact of capital outflows.
4. Focus on Merger Completion Over New Catalysts: The period saw significant procedural progress toward the business combination with BOXABL Inc., including stockholder approval on June 9, 2026. However, the market's attention was primarily on the mechanics and timeline of the merger, with the stock expecting to be renamed BOXABL Inc. and trade as BXBL upon closing. There was a lack of new, material company-specific operational catalysts for BOXABL during this timeframe that would have driven the pre-merger SPAC stock significantly above its established trust and redemption value.
Show less
FG Merger II (FGMC) stock has remained largely at the same level since 2/28/2026 because of the following key factors:
1. SPAC Trust Value and Redemption Price as a Floor: FG Merger II's stock largely remained at its foundational level due to its nature as a Special Purpose Acquisition Company (SPAC), where the trust value and redemption price typically act as a floor for the share price as a business combination approaches. The redemption price for FGMC was approximately $10.40 per share as of June 5, 2026, which anchored the stock's trading range.
2. High Share Redemptions Ahead of Merger: A significant number of shares, approximately 6,615,950, were tendered for redemption by the June 5, 2026 deadline, leading to the removal of about $68.8 million from the trust account. This high redemption rate, while common in de-SPAC transactions, reduced the public float to roughly 1,384,050 shares and the cash remaining in the trust to approximately $14 million, limiting potential upward price momentum before the merger.
3. Structured Capital Management via Forward Purchase Agreement: To manage capital post-redemptions, FG Merger II Corp. entered into an OTC Equity Prepaid Forward Transaction on May 28, 2026. This agreement, partly novated to an affiliate of FGMC's officers and directors, allowed for the potential purchase and holding of up to 3,000,000 shares at a reference price starting at $10.00. This mechanism was designed to provide access to additional growth capital in place of redeemed trust assets, contributing to the stock's stability around its trust value by mitigating the impact of capital outflows.
4. Focus on Merger Completion Over New Catalysts: The period saw significant procedural progress toward the business combination with BOXABL Inc., including stockholder approval on June 9, 2026. However, the market's attention was primarily on the mechanics and timeline of the merger, with the stock expecting to be renamed BOXABL Inc. and trade as BXBL upon closing. There was a lack of new, material company-specific operational catalysts for BOXABL during this timeframe that would have driven the pre-merger SPAC stock significantly above its established trust and redemption value.
Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →
Stock Movement Drivers
Fundamental Drivers
The 1.1% change in FGMC stock from 2/28/2026 to 6/26/2026 was primarily driven by a 0.0% change in the company's Net Income Margin (%).| (LTM values as of) | 2282026 | 6262026 | Change |
|---|---|---|---|
| Stock Price ($) | 10.09 | 10.20 | 1.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 0 | 0 | 0.0% |
| Net Income Margin (%) | ∞% | ∞% | 0.0% |
| P/E Multiple | 106.6 | 75.0 | -29.6% |
| Shares Outstanding (Mil) | 10 | 10 | 0.0% |
| Cumulative Contribution | 0.0% |
Market Drivers
2/28/2026 to 6/26/2026| Return | Correlation | |
|---|---|---|
| FGMC | 1.1% | |
| Market (SPY) | 6.6% | 1.2% |
| Sector (XLF) | 4.7% | -1.6% |
Fundamental Drivers
The 1.8% change in FGMC stock from 11/30/2025 to 6/26/2026 was primarily driven by a 0.0% change in the company's Net Income Margin (%).| (LTM values as of) | 11302025 | 6262026 | Change |
|---|---|---|---|
| Stock Price ($) | 10.02 | 10.20 | 1.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 0 | 0 | 0.0% |
| Net Income Margin (%) | ∞% | ∞% | 0.0% |
| P/E Multiple | 105.9 | 75.0 | -29.1% |
| Shares Outstanding (Mil) | 10 | 10 | 0.0% |
| Cumulative Contribution | 0.0% |
Market Drivers
11/30/2025 to 6/26/2026| Return | Correlation | |
|---|---|---|
| FGMC | 1.8% | |
| Market (SPY) | 7.3% | 1.1% |
| Sector (XLF) | 1.3% | -1.3% |
Fundamental Drivers
The 4.6% change in FGMC stock from 5/31/2025 to 6/26/2026 was primarily driven by a 0.0% change in the company's P/E Multiple.| (LTM values as of) | 5312025 | 6262026 | Change |
|---|---|---|---|
| Stock Price ($) | 9.75 | 10.20 | 4.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | � | 0 | 0.0% |
| Net Income Margin (%) | � | ∞% | 0.0% |
| P/E Multiple | � | 75.0 | 0.0% |
| Shares Outstanding (Mil) | 10 | 10 | 0.0% |
| Cumulative Contribution | 0.0% |
Market Drivers
5/31/2025 to 6/26/2026| Return | Correlation | |
|---|---|---|
| FGMC | 4.6% | |
| Market (SPY) | 25.1% | 0.8% |
| Sector (XLF) | 6.7% | -1.0% |
Fundamental Drivers
nullnull
Market Drivers
5/31/2023 to 6/26/2026| Return | Correlation | |
|---|---|---|
| FGMC | -95.1% | |
| Market (SPY) | 81.3% | 3.0% |
| Sector (XLF) | 77.0% | 0.9% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| FGMC Return | - | 2% | -88% | -90% | 302% | 1% | -95% |
| Peers Return | 0% | 0% | |||||
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 7% | 96% |
Monthly Win Rates [3] | |||||||
| FGMC Win Rate | - | 78% | 67% | 25% | 92% | 67% | |
| Peers Win Rate | 60% | ||||||
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| FGMC Max Drawdown | - | - | -92% | -93% | -22% | -33% | |
| Peers Max Drawdown | |||||||
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: AACP, ACGC, AMAN, APUR, ARCL.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 6/26/2026 (YTD)
About FG Merger II (FGMC)
FG Merger II, operating as iCoreConnect Inc., is a U.S.-based cloud-based software and technology company specializing in HIPAA-compliant Software as a Service (SaaS) solutions. Its primary focus is on serving the healthcare industry by providing secure and efficient tools that help healthcare professionals manage patient information, streamline administrative tasks, and enhance operational security and compliance.
The company offers a diverse suite of products addressing various healthcare needs. Key offerings include iCoreRx for electronic prescriptions and iCorePDMP for checking prescription drug monitoring program histories. For administrative efficiency, it provides iCoreVerify and iCoreVerify+ for automated insurance eligibility verification, iCoreHuddle to identify patient revenue potential, and iCorePay for patient payment processing. iCoreConnect also offers essential infrastructure and communication tools such as iCoreExchange for secure healthcare email, iCoreCloud for data backup, and iCoreIT for managed IT services.
While deeply embedded in the healthcare sector, iCoreConnect extends its security expertise with iCoreSecure, a SaaS solution addressing privacy concerns across various industries, including insurance, real estate, and finance. Its medical coding reference tool, iCoreCodeGenius, further supports healthcare operations. The company's comprehensive offerings aim to improve efficiency, security, and compliance for its broad customer base, primarily within the United States.
AI Analysis | Feedback
Here are 1-3 brief analogies for FG Merger II (iCoreConnect Inc.):
- Salesforce for healthcare practices: It provides a comprehensive suite of cloud-based software tools for healthcare administration, workflow, and compliance.
- An Intuit for doctors: It offers essential software solutions for medical professionals to manage their daily operations, from e-prescribing to patient verification and payment processing.
AI Analysis | Feedback
- iCoreRx: HIPAA compliant electronic prescription software.
- iCorePDMP: A solution that checks a patient's Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances.
- iCoreVerify and iCoreVerify+: HIPAA compliant SaaS solutions for automatically verifying patient insurance eligibility and benefits.
- iCoreHuddle and iCoreHuddle+: Tools designed to instantly reveal the revenue potential of each patient.
- iCoreCodeGenius: A medical coding reference SaaS solution.
- iCoreExchange: A SaaS email solution enabling secure communication and attachment sharing between healthcare professionals.
- iCoreCloud: Provides the ability to back up on-premise servers and computers to the cloud.
- iCorePay: Patient payment processing solutions for managing payments and tracking the revenue cycle.
- iCoreSecure: A secure SaaS solution addressing privacy concerns across various industry sectors, including insurance, real estate, and financial.
- iCoreIT: Offers managed IT services.
AI Analysis | Feedback
FG Merger II (symbol: FGMC) is associated with iCoreConnect Inc., a company that provides cloud-based software and technology solutions. iCoreConnect Inc. sells its products and services primarily to other companies and organizations, not directly to individual consumers. The background information does not provide specific names of customer companies.
Based on the description of its products, iCoreConnect Inc.'s major customer categories are:
- Healthcare Providers: This is the primary customer segment, including individual medical and dental practices, clinics, and potentially smaller healthcare facilities. These customers utilize a wide range of iCoreConnect's HIPAA-compliant SaaS solutions, such as electronic prescribing (iCoreRx), prescription drug monitoring (iCorePDMP), insurance eligibility verification (iCoreVerify), secure email (iCoreExchange), patient payment processing (iCorePay), and medical coding references (iCoreCodeGenius).
- Businesses in Regulated Industries: Companies requiring secure data exchange and privacy solutions, such as those in the insurance, real estate, and financial sectors, leverage iCoreSecure to meet their compliance and security needs.
- General Businesses Needing IT Managed Services: Various companies across different industries that require comprehensive IT infrastructure management, support, and cloud backup services (iCoreIT and iCoreCloud).
AI Analysis | Feedback
null
AI Analysis | Feedback
Robert McDermott, Chief Executive Officer
Robert McDermott has served as the President and CEO of iCoreConnect, Inc. (Florida) since 2021, and was previously the Chairman, President, and CEO. He is recognized as an expert in HIPAA-compliant communications and online data security. Before his tenure at iCoreConnect, Mr. McDermott co-founded the company and also started, managed, and operated six other technology-oriented companies, three of which were successfully acquired by major corporations. He has a track record of leading Inc 500 and Inc 5000 companies and has been involved in five company exits.
Hal Goetsch, Chief Financial OfficerHal Goetsch was appointed Chief Financial Officer of iCoreConnect Inc. effective March 8, 2021. He is recognized as a seasoned finance expert with extensive experience in SaaS strategy, investor relations, and contract negotiations. Prior to joining iCoreConnect, Mr. Goetsch was the CFO at DigniFi, a subscription-based fintech company. He also spent two decades as an equity investment manager at firms such as Citadel LLC, Alydar Capital, and The Boston Company Asset Management. Mr. Goetsch advises start-ups in the SaaS sector and is a former U.S. Navy nuclear power trained submarine officer. He holds an MBA from Harvard Business School and a Bachelor of Science in Industrial Management from Purdue University.
Jeff Stellinga, Chief Operating Officer Muralidar Chakravarthi, Chief Technology OfficerAI Analysis | Feedback
The key risks to FG Merger II (symbol: FGMC), which operates as iCoreConnect Inc., primarily revolve around its financial viability and operational stability.
- Ability to Continue as a Going Concern: iCoreConnect Inc. faces substantial doubt about its ability to continue as a going concern without successful fundraising efforts. The company is experiencing liquidity challenges and a significant working capital deficit, relying heavily on future capital raises to finance its operations. This financial instability is a critical issue.
- Regulatory Compliance and Security Risks: As a cloud-based software and technology company providing HIPAA-compliant services, iCoreConnect Inc. is exposed to significant regulatory risks. Non-compliance with HIPAA regulations and potential liability for breaches of health information privacy are major concerns. Breaches in security measures could lead to unauthorized access to sensitive data, damaging the company's reputation and resulting in legal liabilities.
- Limited Operating History and Internal Control Weaknesses: The company has a limited operating history, which makes it challenging to accurately evaluate its future business prospects. Furthermore, the restatement of financial statements due to accounting errors highlights weaknesses in internal controls, potentially impacting the reliability of its financial reporting.
AI Analysis | Feedback
null
AI Analysis | Feedback
The addressable markets for iCoreConnect Inc.'s main products and services, operating under the symbol FGMC, primarily within the U.S. region, are sized as follows:
- iCoreRx (HIPAA compliant electronic prescription software): The North America e-prescribing market size reached an estimated USD 2.17 billion in 2025. The global e-prescribing market size was valued at approximately USD 5.98 billion in 2025 and is projected to reach around USD 59.92 billion by 2035, growing at a Compound Annual Growth Rate (CAGR) of 25.92% from 2026 to 2035. North America held the largest market share, accounting for 46% of the global revenue in 2025.
- iCorePDMP (Prescription Drug Monitoring Program solution): A specific commercial addressable market size (in terms of revenue for solutions providers) for Prescription Drug Monitoring Programs (PDMPs) is not readily available. These programs are primarily state-level electronic databases for tracking controlled substance prescriptions. In 2024, the mean operational annual budget for state PDMPs in the U.S. was approximately $1.355 million. Most U.S. physicians (78.3%) reported using PDMPs in 2018–2019.
- iCoreVerify and iCoreVerify+ (HIPAA compliant SaaS solution for insurance eligibility verification): The global market for Medical Insurance Eligibility Verification Software was estimated at US$ 2.431 billion in 2025 and is projected to reach US$ 3.928 billion by 2032, exhibiting a CAGR of 7.1% from 2026 to 2032. North America is expected to remain a dominant region in this market. The broader insurance eligibility verification market size is expected to grow from $2.39 billion in 2025 to $2.57 billion in 2026 at a CAGR of 7.5%, reaching $3.4 billion by 2030.
- iCoreHuddle and iCoreHuddle+ (tool to instantly reveal the revenue potential of each patient) and iCorePay (patient payment processing solutions): These services address parts of the Patient Engagement Solutions and Healthcare Digital Payment markets.
- Patient Engagement Solutions (U.S. region): The U.S. patient engagement solutions market size was estimated at USD 7.59 billion in 2024 and is expected to reach USD 9.10 billion in 2025. It is predicted to grow to approximately USD 25.21 billion by 2034, expanding at a CAGR of 14.68% from 2025 to 2034.
- Healthcare Digital Payment Solutions (U.S. region): The U.S. healthcare digital payment market size was approximately USD 3.98 billion in 2024 and is projected to reach around USD 26.83 billion by 2034, with a CAGR of 21.02% from 2025 to 2034.
- iCoreCodeGenius (medical coding reference SaaS solution): The U.S. medical coding market size was estimated at USD 21.89 billion in 2024 and is expected to grow at a CAGR of 10.00% from 2025 to 2033. The North American medical coding market dominated the global market with a 48.0% share in 2024.
- iCoreExchange (SaaS email solution for healthcare professionals) and iCoreSecure (secure SaaS solution): These products fall under the HIPAA Compliant Messaging Software market. The global HIPAA Compliant Messaging Software Market was valued at USD 1.54 billion in 2024 and is expected to reach USD 2.80 billion by 2030, with a CAGR of 9.8%. The secure messaging in healthcare market (global) was estimated at US$ 0.85 billion in 2023 and is expected to reach US$ 3.14 billion by 2031 at a CAGR of 17.80%.
- iCoreCloud (cloud-based backup): The U.S. cloud backup market was valued at USD 1.25 billion in 2023 and is expected to reach USD 10.11 billion by 2032, growing at a CAGR of 26.16% from 2024-2032. North America held approximately 39% of the global cloud backup market revenue share in 2023. The global healthcare cloud infrastructure market size was estimated at USD 89.78 billion in 2025 and is anticipated to reach around USD 413.84 billion by 2035.
- iCoreIT (IT managed services): The United States managed services market specifically linked to healthcare could exceed USD 18 billion by 2031, with healthcare projected to be the fastest-growing vertical at a 12.24% CAGR. More broadly, the U.S. healthcare IT market size for IT solutions is projected at $176.6 billion, accounting for 63% of global healthcare IT industry spending in 2025. The global healthcare IT services market was calculated at USD 72.23 billion in 2025 and is expected to reach around USD 212.97 billion by 2035. North America led this market with a 36.4% share in 2025.
AI Analysis | Feedback
FG Merger II (symbol: FGMC), now operating as iCoreConnect Inc. (NASDAQ: ICCT), is anticipated to drive future revenue growth over the next 2-3 years through several key strategies:
- Expansion of Customer Base and Strategic Partnerships: iCoreConnect aims to increase its revenue by expanding its market presence, particularly through new and existing partnerships with dental and medical associations. The company has over 100 agreements with state or regional healthcare associations, and it expects to attract larger enterprise clients, leading to substantial growth in its subscriber base.
- Growth of Recently Launched Products and Cross-Selling on the iCoreEnterprise Platform: The introduction of the iCoreEnterprise Platform, which offers single sign-on access to 17 SaaS products, is a significant growth driver. This platform enhances user experience, attracts larger enterprise clients, and increases the likelihood of customers adopting additional functionalities across its suite of products, including high-demand solutions like iCorePay and iCoreVerifyPro.
- Strategic Acquisitions: iCoreConnect actively pursues acquisitions of products and services that complement its existing platform offerings. The company has a history of successfully integrating acquired solutions, such as iCorePay and iCoreVerifyPro, which contribute to its recurring revenue growth. This strategy allows for the expansion of its service portfolio and market reach.
- Expansion of Sales Force and Organic Growth Initiatives: The company plans to continuously expand its sales force to drive organic growth by increasing the adoption of its cloud-based software solutions among healthcare providers, dental service organizations, hospitals, and insurance payors. The capital secured from its business combination with FG Merger Corp. is expected to accelerate these growth initiatives.
AI Analysis | Feedback
Share Repurchases
- Prior to its business combination with iCoreConnect Inc. on August 25, 2023, FG Merger Corp. (FGMC) experienced redemptions of 6,292,008 shares, representing 78.16% of its shares. This left the SPAC with $18.72 million in its trust account.
Share Issuance
- In connection with the business combination on August 25, 2023, shareholders of FG Merger Corp. who did not exercise their redemption rights had 100% of their equity converted into preferred stock of the combined company.
- iCoreConnect Inc. raised capital through the issuance of common stock and convertible preferred stock, including 480,000 Series A Convertible Preferred stock for FeatherPay and 84,000 for Verifi Dental.
- The company also issued 763,161 shares of common stock related to the conversion of Series A Convertible Preferred Stock and obtained $303,619 from common stock issuance.
Inbound Investments
- The business combination on August 25, 2023, brought $18.72 million in gross proceeds to the combined company from FG Merger Corp.'s trust account, after redemptions.
- The transaction valued iCoreConnect at a pro forma enterprise value of $98.0 million.
Outbound Investments
- iCoreConnect Inc. announced the acquisition of substantially all assets of the Healthcare Circle of Excellence (HCofE).
- In 2024, iCoreConnect sold the assets of its Managed IT Services (MSP and MSaaS) to focus on its core Software as a Service (SaaS) opportunities.
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 9.96 |
| Mkt Cap | 0.1 |
| Rev LTM | 0 |
| Op Inc LTM | -1 |
| FCF LTM | 2 |
| FCF 3Y Avg | - |
| CFO LTM | 2 |
| CFO 3Y Avg | - |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | - |
| Rev Chg 3Y Avg | - |
| Rev Chg Q | - |
| QoQ Delta Rev Chg LTM | - |
| Op Inc Chg LTM | -638.8% |
| Op Inc Chg 3Y Avg | - |
| Op Mgn LTM | - |
| Op Mgn 3Y Avg | - |
| QoQ Delta Op Mgn LTM | - |
| CFO/Rev LTM | - |
| CFO/Rev 3Y Avg | - |
| FCF/Rev LTM | - |
| FCF/Rev 3Y Avg | - |
Price Behavior
Price Behavior
| Market Price | $10.20 | |
| Market Cap ($ Bil) | 0.1 | |
| First Trading Date | 04/19/2022 | |
| Distance from 52W High | -31.5% | |
| 50 Days | 200 Days | |
| DMA Price | $10.28 | $9.91 |
| DMA Trend | indeterminate | up |
| Distance from DMA | -0.8% | 2.9% |
| 3M | 1YR | |
| Volatility | 113.3% | 56.4% |
| Downside Capture | -23.01 | -8.22 |
| Upside Capture | -8.21 | -2.51 |
| Correlation (SPY) | 1.4% | 0.9% |
FGMC Betas & Captures as of 5/31/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -0.02 | -0.01 | -0.01 | -0.00 | -0.00 | 0.54 |
| Up Beta | -0.31 | -0.08 | -0.07 | -0.02 | -0.02 | 0.85 |
| Down Beta | -0.02 | -0.05 | -0.02 | -0.03 | 0.01 | 1.16 |
| Up Capture | 21% | 10% | 7% | 4% | 3% | -5% |
| Bmk +ve Days | 13 | 28 | 36 | 67 | 141 | 432 |
| Stock +ve Days | 10 | 19 | 26 | 52 | 110 | 304 |
| Down Capture | -16% | -9% | -5% | -4% | -6% | 91% |
| Bmk -ve Days | 7 | 13 | 27 | 57 | 109 | 318 |
| Stock -ve Days | 6 | 12 | 19 | 39 | 85 | 333 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with FGMC | |
|---|---|---|---|---|
| FGMC | 3.4% | 56.6% | 0.25 | - |
| Sector ETF (XLF) | 5.5% | 14.5% | 0.15 | -1.1% |
| Equity (SPY) | 21.2% | 12.4% | 1.26 | 0.8% |
| Gold (GLD) | 21.8% | 27.7% | 0.70 | -0.4% |
| Commodities (DBC) | 21.8% | 18.6% | 0.92 | 0.9% |
| Real Estate (VNQ) | 16.1% | 13.6% | 0.85 | 0.8% |
| Bitcoin (BTCUSD) | -44.7% | 42.5% | -1.27 | 3.3% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with FGMC | |
|---|---|---|---|---|
| FGMC | -45.0% | 264.9% | 0.30 | - |
| Sector ETF (XLF) | 10.7% | 18.6% | 0.44 | 0.9% |
| Equity (SPY) | 13.4% | 17.1% | 0.61 | 2.7% |
| Gold (GLD) | 17.8% | 18.3% | 0.79 | 1.0% |
| Commodities (DBC) | 7.4% | 19.5% | 0.28 | -3.7% |
| Real Estate (VNQ) | 3.4% | 18.9% | 0.08 | -0.0% |
| Bitcoin (BTCUSD) | 10.7% | 54.0% | 0.39 | 4.7% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with FGMC | |
|---|---|---|---|---|
| FGMC | -25.8% | 264.9% | 0.30 | - |
| Sector ETF (XLF) | 13.3% | 22.1% | 0.55 | 0.9% |
| Equity (SPY) | 15.2% | 18.0% | 0.72 | 2.7% |
| Gold (GLD) | 11.8% | 16.1% | 0.60 | 1.0% |
| Commodities (DBC) | 5.9% | 18.0% | 0.26 | -3.7% |
| Real Estate (VNQ) | 5.6% | 20.7% | 0.23 | -0.0% |
| Bitcoin (BTCUSD) | 54.6% | 66.4% | 0.95 | 4.7% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Updated 6/3/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
Industry Resources
| Financials Resources |
| Federal Reserve Economic Data |
| Federal Reserve |
| FDIC Data |
| American Banker |
| The Banker |
| Banking Technology |
| Multi-Sector Holdings Resources |
| McKinsey & Company Insights |
| Harvard Business Review |
| ValueWalk |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.
Core Cache Last Updated: 6/26/2026